Tenaya Therapeutics, Inc. Stock Analysis & AI Score
Tenaya Therapeutics, Inc. (TNYA) has an ST Score of 37.6 (C), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $2.33 price target (+275.8% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Tenaya Therapeutics, Inc. (TNYA) has an ST Score of 37.6 (C), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $2.33 price target (+275.8% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityF
All factor grades
- ForecastA
- GrowthB
- ValuationC
- Financial StrengthD+
- MomentumD
- ProfitabilityF
- Piotroski3/9
Contact
TNYA stock: frequently asked questions
What is TNYA's ST Score?
Tenaya Therapeutics, Inc. (TNYA) has an ST Score of 37.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is TNYA a buy, hold, or sell?
Analysts rate TNYA a Buy, with a price target of $2.33 (+275.8% vs the current price). Our ST Score grades it C (37.6/100). The ST Score is a data-driven signal, not a recommendation.
What are TNYA's factor grades?
Valuation C, Profitability F, Financial Strength D+, Momentum D, Growth B, Forecast A.
What is TNYA's valuation grade?
Tenaya Therapeutics, Inc. (TNYA) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is TNYA's growth grade?
Tenaya Therapeutics, Inc. (TNYA) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is TNYA's profitability grade?
Tenaya Therapeutics, Inc. (TNYA) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is TNYA's financial strength grade?
Tenaya Therapeutics, Inc. (TNYA) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for TNYA?
The average analyst price target for Tenaya Therapeutics, Inc. (TNYA) is $2.33 from 6 analysts, which is +275.8% versus the recent price of $0.62.
What is TNYA's Piotroski score?
Tenaya Therapeutics, Inc. (TNYA) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.